Versions Compared

Old Version 18

changes.mady.by.user Former user

Saved on

compared with

New Version 19

changes.mady.by.user Former user

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Image Modified


Project Scope

This project team will create a White Paper with recommendations for listings to include in Clinical Study Reports based on shared learning from cross-industry participants, to address changes in data availability over time.



Project LeadsEmails
Mercy Navarronavarrom@gene.com 
Nancy Brucken 

nbrucken@csg-inc.com

Paula Rowley (PHUSE Project Assistant)paula@phuse.global 


Objectives & DeliverablesTimelines

White Paper providing recommendations for listings to include CSRs and submissions (if any), with a summary of example alternatives to static listings.

Public Review

Final Paper



Q12021

Q22021



Project MembersOrganisation
Anna LeathEli Lilly
Kim MusgraveAmgen
Maria DaltonGSK
Mary NilssonEli Lilly
Raj PhadtareCorvus Pharma


Status
colourBlue
titleCurrent Status
 Q12021

Draft White Paper almost ready to be shared with Working Group Leads​. Presented at the FDA Quarterly meeting on 7th April​. Project Lead writing abstract for CDISC Interchange